The MOLOGEN AG Supervisory Board

 

Oliver Krautscheid
Chairman of the Supervisory Board

Frankfurt/Main, Germany

Oliver Krautscheid has been a member of multiple supervisory boards, a financial expert and management consultant for more than 15 years. 

He is currently a partner in Value Investor Partners GbR, a family investment company founded by him, as well as managing chairman of the board of directors of The Fantastic Company AG, which has its head office in Switzerland.

He previously worked for various international consulting and auditing companies in Germany and in London including: Arthur Andersen, McKinsey & Co. and KPMG. At the latter, he worked as a partner in the area of Financial Advisory Services until 2004 and managed the "Strategic & Commercial Intelligence" business unit co-founded by him.

Mr. Krautscheid has advised on M&A transactions for major pharmaceutical companies and for biotech and venture capital. He graduated from the University of Cologne with a degree in business administration.

Besides his role at MOLOGEN AG, Mr. Krautscheid is a member of the following statutory supervisory boards, or comparable domestic or foreign supervisory committees of business enterprises:

  • CD Deutsche Eigenheim, Berlin / former DESIGN Bau AG, Kiel (chairman of the supervisory board)
  • EASY SOFTWARE AG, Mülheim an der Ruhr (chairman of the supervisory board)
  • EPG (Engineered nanoProducts Germany) AG, Griesheim (chairman of the supervisory board)

 

Dr. med. Stefan M. Manth
Vice Chairman of the Supervisory Board

Basel, Switzerland

Dr. Manth is a physician with additional training in business (MBA from INSEAD) and has been working since the 1980s for the pharmaceutical and biotech industries. He spent 20 years working for the Roche Group (Roche Pharma and Chugai).

His extensive management experience includes areas such as product development, clinical research, marketing and distribution of prescription and prescription-free drugs, organizational and personnel development, corporate, product and group strategy, corporate management, acquisition and integration, turn-around and change management.

He particularly distinguished himself, by establishing and developing the oncology business of the Roche Group, by far the current global leader in this therapeutic area.

Dr. Manth has been involved with various supervisory bodies in Germany and abroad for more than 20 years.

 

 

Susanne Klimek

Managing Director of SALVATOR Vermögensverwaltungs GmbH, Munich

Susanne Klimek began her career in the banking sector. From 1985 onwards, she held senior positions in various departments of the Bayerische Hypotheken- und Wechsel-Bank AG, latterly heading the HR department of the company's Investment Management division. Mrs. Klimek joined the SALVATOR Group in 1996. As Managing Director, she handles the purchase, sale and financing of residential real estate and the management and support of company holdings.